I don’t understand your point in paragraph #2. Regardless of how the 2013 date for the Lovenox trial was arrived at, it’s very bullish for MNTA that this case is not perceived as being urgent by anybody.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”